Twenty children with a variety of metabolic liver diseases were given two d
oses of hepatitis A vaccine. Adverse reactions were mild. All subjects resp
onded to vaccine with seroconversion to hepatitis A virus antibodies after
the first dose, regardless of transaminase values, and had a booster effect
from the second doses.